Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1 1

Status

Completed 428Recruiting 126Unknown 122Terminated 122Active not recruiting 111Withdrawn 45Not yet recruiting 18Suspended 3Enrolling by invitation 3No longer available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Gastrointestinal 1

Conditions

Smoldering Multiple Myeloma 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Esophageal Squamous Cell Carcinoma 1

Interventions

Specimen Handling 7Educational Status 7Cisplatin 7Standard of Care 6Interviews as Topic 6Blood Specimen Collection 6Radiotherapy 5Nivolumab 5Chemoradiotherapy 5Carboplatin 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Paclitaxel 4Oxaliplatin 4Fluorouracil 4Fluorodeoxyglucose F18 4Drug Therapy 4lenvatinib 3camrelizumab 3Practice Guidelines as Topic 3Patient Navigation 3Methods 3Magnetic Resonance Spectroscopy 3Magnetic Resonance Imaging 3Lenalidomide 3Gemcitabine 3Exercise 3Early Intervention, Educational 3Dexamethasone 3Cytarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Enrolling by invitation × OTHER × Dexamethasone × Clear all
NCT07014462 2025-10-06

DLIT-AML

University of Vermont

Phase 1 Enrolling by invitation
20 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT07016737 2025-06-12

ESO-Nanjing12

Jiangsu Cancer Institute & Hospital

Phase 3 Enrolling by invitation
79 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT03815279 2019-08-16

iStopMM

Landspitali University Hospital

Phase 2 Enrolling by invitation
80 enrolled
Plasma cell

Smoldering Multiple Myeloma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡